Patent ID: 6071966
Filing Date: 2000-06-06
Classification: A61K

Abstract:
A method-of-treating a living animal for alleviation of a condition which is alleviated by an NMDA receptor antagonist, or for its immunomodulatory, antimalarial, anti-Borna virus, or anti-Hepatitis C effect, comprising the step of administering to the said living animal an amount of a 1-aminoalkylcyclohexane compound selected from the group consisting of those of the formula ##STR12## wherein R* is --(CH.sub.2).sub.n, (CR.sup.6 R.sup.7).sub.m --NR.sup.8 R.sup.9wherein n+m=0, 1, or 2wherein R.sup.1 through R.sup.7 are independently selected from the group consisting of hydrogen and lower-alkyl (1-6C), wherein R.sup.8 and R.sup.9 are independently selected from the group consisting of hydrogen and lower-alkyl (1-6C) or together represent lower-alkylene --(CH.sub.2).sub.x -- wherein x is 2 to 5, inclusive, and optical isomers, enantiomers, hydrates, and pharmaceutically-acceptable salts thereof, which is effective for the said purpose.